SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against a broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
Disclaimer: This is not financial advice.
Upcoming Event: Preclinical Data Release on 04/24/2024
This is a highly speculative investment opportunity.
Recent News Highlights:
SCYNEXIS has been reaffirmed a 'Buy' rating due to strong financials and promising pipeline prospects.
The 'Buy' rating was also reaffirmed based on the success of Ibrexafungerp and a strong partnership with GSK.
Key Price Levels to Watch:
Monitor the resistance levels at $1.70, $1.85, and $2.00. Breaking these levels could indicate a potential upward movement. Consider taking partial profits at these levels to secure gains.
Stop Loss (SL): Set below $1.30 to minimize risk.
Take Profit (TP): Target approximately $2.15.
Additional information can be found in the accompanying chart.
Please trade with caution.
Disclaimer: This is not financial advice.
Upcoming Event: Preclinical Data Release on 04/24/2024
This is a highly speculative investment opportunity.
Recent News Highlights:
SCYNEXIS has been reaffirmed a 'Buy' rating due to strong financials and promising pipeline prospects.
The 'Buy' rating was also reaffirmed based on the success of Ibrexafungerp and a strong partnership with GSK.
Key Price Levels to Watch:
Monitor the resistance levels at $1.70, $1.85, and $2.00. Breaking these levels could indicate a potential upward movement. Consider taking partial profits at these levels to secure gains.
Stop Loss (SL): Set below $1.30 to minimize risk.
Take Profit (TP): Target approximately $2.15.
Additional information can be found in the accompanying chart.
Please trade with caution.
Not
hit 1.95 todayİşlem kapandı: hedefe ulaştı
wow hit 2.9
Join Discord channel:
whop.com/marketplace/contingent-traders/
contingenttrader.com/
whop.com/marketplace/contingent-traders/
contingenttrader.com/
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.
Join Discord channel:
whop.com/marketplace/contingent-traders/
contingenttrader.com/
whop.com/marketplace/contingent-traders/
contingenttrader.com/
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.